Glycosmedia

Diabetes News Service

  • News
  • Archive
  • Categories & Tags
  • Journal Watch
  • Updates
  • Education
  • Reviews
  • About us ▼
    • About Glycosmedia
    • Editorial Team
    • Frequently asked questions
    • Comments
    • Press Releases
    • Disclaimer
  • Subscribe
  • Contact

Diabetes News September 11th 2009

September 11th 2009

GP Surgery Network
To support diabetes management in primary care, Diabetes UK is launching the GP Surgery Network. The first mailing will commence in September (Diabetes UK)

Scientists discover new genetic variation that contributes to diabetes
Scientists have identified a genetic variation in people with type 2 diabetes that affects how the body’s muscle cells respond to the hormone insulin (Imperial College London)

The DCCT Lives On! Intensive Glucose Control Halves Complications
Although the ten-year study ended in 1993, researchers have continued to follow about 90 percent of the nearly 1,500 original DCCT volunteers (Diabetes Health)

JDRF shows that CGMs improve control and reduce hypoglycaemia
People who use their CGM six days a week or more are likely to see a significant improvement in their HbA1c than people who use the CGM less regularly (JDRF)

Gestational Diabetes: Caring for Women During and After Pregnancy
Clinician Summary Guide (AHRQ, UK)

Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy
A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes (Diabetes Care)

New insights in diabetic autonomic neuropathy in children and adolescent
This article reviews recent developments in knowledge of epidemiology, pathogenesis, clinical symptoms, diagnosis and therapy of DAN (Abstract – European Journal of Endocrinology)

Post Match Report: Around U Soccer Skills Day
Wow! What a day! Over 140 children with type 1 diabetes travelled to the home of West Ham United, the Boleyn Ground, on 21st August for the first ever Around U Soccer Skills Day (Diabetes.co.uk)

Perioperative intensive insulin therapy using artificial endocrine pancreas in patients undergoing pancreatectomy
To reduce the postoperative infectious complications related to hyperglycemia and iatrogenic hypoglycemia caused by conventional blood glucose control, perioperative use of an artificial pancreas is recommended as an ideal method for tight glycemic control after pancreatic surgery (World Journal of Gastroenterology)

Effect of Android to Gynoid Fat Ratio on Insulin Resistance in Obese Youth
Android fat distribution is associated with an increased insulin resistance in obese children and adolescents. An android to gynoid fat ratio based on dual-energy x-ray absorptiometry measurements is a useful and simple technique to assess distribution of body fat associated with an increased risk of insulin resistance (Archives of Pediatics & Adolescent Medicine)

Annual Professional Conference 2010
Diabetes: challenges in all ages (DiabetesUK)

Children get type 2 diabetes too
This article presents the case of a girl, Aroha, 13 years of age and of Polynesian descent, who presents with high random blood glucose levels. It outlines the diagnosis, treatment and prognosis of T2DM in children and adolescents (Australian Family Physician)

Oramed Pharmaceuticals Commences Human Clinical Trials of an Oral GLP-1 Analog
ORMD 0901 is being developed as an oral dosage form of a GLP-1 Analog aimed at improving glycemic control in adults with type 2 diabetes (Oramed Pharmaceuticals)

Oral-Lyn – Oral Insulin for Types 1 and 2 Diabetes
Approval of Oral-Lyn by the Ecuadorian Ministry of Public Health was based on data from clinical trials conducted in Ecuador which involved more than 250 patients with type 2 diabetes. These showed that Oral-Lyn had comparable efficacy to prandial insulin injections in this patient population (Drug Development Technology)

Amylin and Biocon collaborate to develop a peptide therapeutic for treating diabetes
Amylin Pharmaceuticals and Biocon, Limited announced today that they have entered into an exclusive agreement to jointly develop, commercialize and manufacture a novel peptide therapeutic for the potential treatment of diabetes (Medical News)

Categories: News Pre-2012

Subscribe

subscribe-iconFREE weekly updates by email Please CLICK HERE

Platinum Sponsor

Sanofi Diabetes

Gold Sponsors

MSDAstraZenecaNapp DiabetesBoehringer Ingelheim LillyNovo Nordisk

Silver Sponsors

Welsh Endocrinology and Diabetes Society (WEDS)Abbott Diabetes Care

FUNDING NOTICE

The Glycosmedia website and newsletter has been made possible with funding support from our sponsors. None of our sponsors have control over the content of the website, newsletter, apps, Twitter feed or RSS newsfeed.

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Advertisers

CRC Press

The organisations advertising in this section do not have any input into, or editorial control over the content of this website.

Join us on Facebook

Join us on Facebook

Share Glycosmedia

Follow us on Twitter

My Tweets

Glycosmedia App

mobileA Glycosmedia iPhone/iPad App is available FREE from the iTunes store.


Sponsorship and Advertising

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com


HONcode Standard

HONConduct783211_s2This site complies with the HONcode standard for trustworthy health information: verify here.

Copyright © 2018 Glycosmedia Partnership